Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24665
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Papamarcaki, T. | en |
dc.contributor.author | Kouklis, P. D. | en |
dc.contributor.author | Kreis, T. E. | en |
dc.contributor.author | Georgatos, S. D. | en |
dc.date.accessioned | 2015-11-24T19:42:36Z | - |
dc.date.available | 2015-11-24T19:42:36Z | - |
dc.identifier.issn | 0021-9258 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24665 | - |
dc.rights | Default Licence | - |
dc.subject | Animals | en |
dc.subject | Antibodies, Anti-Idiotypic/immunology | en |
dc.subject | Antibodies, Monoclonal/immunology | en |
dc.subject | Epitopes | en |
dc.subject | Intermediate Filament Proteins/immunology/*ultrastructure | en |
dc.subject | Lamin Type B | en |
dc.subject | Lamins | en |
dc.subject | *Membrane Glycoproteins | en |
dc.subject | Mice | en |
dc.subject | *Nerve Tissue Proteins | en |
dc.subject | Nuclear Matrix/ultrastructure | en |
dc.subject | Nuclear Proteins/immunology/*ultrastructure | en |
dc.subject | Protein Binding | en |
dc.subject | Protein Conformation | en |
dc.subject | Rats | en |
dc.subject | Vimentin/immunology | en |
dc.title | The "lamin B-fold". Anti-idiotypic antibodies reveal a structural complementarity between nuclear lamin B and cytoplasmic intermediate filament epitopes | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/1718975 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 1991 | - |
heal.abstract | Previous studies have shown that nuclear lamin B binds specifically to the C-terminal domains of type III intermediate filament (IF) proteins under in vitro conditions. To further explore such site-specific interactions, we have used a two-step anti-idiotypic antibody approach. First, a monoclonal antibody disrupting the cytoplasmic IF network organization of living cells (mAb7A3) (Matteoni, R., and Kreis, T. E. (1987) J. Cell Biol. 105, 1253-1265) was characterized. Epitope mapping demonstrated that this antibody recognized a site located in the C-terminal domains of vimentin and peripherin (type III IF proteins). mAb7A3 was able to inhibit more than 80% of the in vitro binding of nuclear lamin B to PI, a synthetic peptide modeled after the C-terminal domain of peripherin that comprises a lamin B-binding site (Djabali, K., Portier, M. M., Gros, F., Blobel, G., and Georgatos, S. D. (1991) Cell 64, 109-121). In a second step, animals were immunized with mAb7A3 and the resulting anti-idiotypic sera were screened. Two of these antisera reacted specifically with nuclear lamin B but not with type A lamins or cytoplasmic IF proteins. The anti-lamin B activity of one of the antisera was isolated by affinity chromatography using a lamin B-agarose matrix. The reaction of these affinity-purified antibodies with lamin B was inhibited by mAb7A3. Furthermore, the anti-lamin B antibodies reacted with Fab fragments of mAb7A3 and abolished binding of lamin B to PI. From these data we conclude that anti-idiotypic antibodies against the paratope of mAb7A3 recognize specific epitopes of the lamin B molecule that have shapes complementary to the one of the C-terminal domain of type III IF proteins. We speculate that these (regional) conformations, which we term the "lamin B-fold," may also occur in non-lamin proteins that mediate the anchorage of IFs to various membranous organelles. | en |
heal.journalName | J Biol Chem | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Georgatos-1991-the lamin b.pdf | 2.78 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License